OncoAssure

OncoAssure Prostate Demonstrate Superior Prognostic Value at AUA 2026 oncoassure.com/news/oncoassur…

OncoAssure and GoPath Diagnostics Announce Agreement for Provision of Next-Generation Prostate Cancer Prognostic Test in US Market lnkd.in/eSkpiwwZ

Join Us at AUA 2026 — OncoAssure - Precision Tests for Oncology

OncoAssure Announces Collaboration with Leading US Medical Centre for Prostate Cancer Test Validation Study oncoassure.com/news/medical-c…

OncoAssure is excited to exhibit at the Texas Urological Society Annual Meetingthis July 17-18 in San Antonio! Come meet the OncoAssure team and learn how the next generation OncoAssure Prostate test can enhance treatment decisions at key stages of prostate cancer care.

OncoAssure Announces US Launch of Novel Prostate Cancer Prognostic Test oncoassure.com/news/34ky3n8n2…

Just released: genomeweb interview with OncoAssure CEO Desmond O'Leary genomeweb.com/cancer/ireland…

DiaCarta, Inc. a pioneer in molecular diagnostic test development for cancer and infectious diseases, based in USA, has established a strategic collaboration with @OncoAssure, an Irish medical diagnostics company headquartered @NovaUCD. @DiaCarta_DX ucd.ie/innovation/new…

OncoAssure news! We are collaborating with DiaCarta to launch our prostate cancer test. oncoassure.com/news/diacarta-…

OncoAssure Clinical Study Validates Novel Test for Prostate Cancer Management oncoassure.com/news/oncoassur…

OncoAssure Attending ASCO GU Cancer Symposium 2023 oncoassure.com/news/oncoassur…

OncoAssure Announce Results of Clinical Validation of Prognostic Test for Prostate Cancer oncoassure.com/news/oncoassur…

OncoMasTR Breast Assay Acquired by Cepheid Inc. oncoassure.com/news/oncomastr…

OncoAssure Chief Scientific Officer Professor William Gallagher Awarded SFI Researcher of the Year 2021 oncoassure.com/news/oncoassur…